Cargando…
Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study
(1) Background: SARS-CoV-2 infection is notably mild in children, though comorbidities may increase the risk of hospitalization and may represent a risk for increased disease severity. There is an urgent need for targeted therapies with an acceptable efficacy and safety profile. To date, most of the...
Autores principales: | Minotti, Chiara, Mengato, Daniele, De Pieri, Marica, Trivellato, Sabrina, Francavilla, Andrea, Di Chiara, Costanza, Liberati, Cecilia, Mattera, Raffaele, Biffi, Alessandra, Giaquinto, Carlo, Venturini, Francesca, Donà, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867507/ https://www.ncbi.nlm.nih.gov/pubmed/36680232 http://dx.doi.org/10.3390/v15010192 |
Ejemplares similares
-
Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2
por: Di Chiara, Costanza, et al.
Publicado: (2022) -
Therapeutic Options and Outcomes for the Treatment of Children with Gram-Positive Bacteria with Resistances of Concern: A Systematic Review
por: Chiusaroli, Lorenzo, et al.
Publicado: (2023) -
Alternative Antimicrobial Irrigation Strategies for the Treatment of Infections in Children: A Review of the Existing Literature
por: Di Chiara, Costanza, et al.
Publicado: (2023) -
Enteral Linezolid as an Effective Option to Treat an Extremely Preterm Infant with Bacillus cereus Sepsis
por: Minotti, Chiara, et al.
Publicado: (2022) -
COVID-19 and MIS-C treatment in children—results from an international survey
por: Donà, Daniele, et al.
Publicado: (2023)